mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Predicted mutations | |||||||
|---|---|---|---|---|---|---|---|
| evidence | seq id | position | mutation | freq | annotation | gene | description |
| RA | NZ_CP022686 | 197,859 | G→T | 10.8% | A472S (GCA→TCA) | dtpA → | dipeptide/tripeptide permease DtpA |
| RA | NZ_CP022686 | 228,613 | A→T | 13.7% | D78E (GAT→GAA) | ydhT ← | protein YdhT |
| RA | NZ_CP022686 | 235,029 | G→T | 8.5% | E15* (GAA→TAA) | pykF → | pyruvate kinase PykF |
| RA | NZ_CP022686 | 235,834 | C→T | 15.5% | S283F (TCC→TTC) | pykF → | pyruvate kinase PykF |
| RA | NZ_CP022686 | 235,864 | C→T | 5.6% | A293V (GCA→GTA) | pykF → | pyruvate kinase PykF |
| RA | NZ_CP022686 | 349,092 | A→C | 8.7% | N602T (AAC→ACC) | yeaG → | protein kinase YeaG |
| RA | NZ_CP022686 | 372,574 | A→C | 17.0% | N275T (AAC→ACC) | sdaA → | L‑serine ammonia‑lyase |
| RA | NZ_CP022686 | 418,374 | T→G | 13.7% | F48V (TTT→GTT) | znuB → | zinc ABC transporter permease subunit ZnuB |
| RA | NZ_CP022686 | 457,894 | Δ1 bp | 100% | pseudogene (288/997 nt) | CIW80_RS02445 ← | DUF968 domain‑containing protein |
| RA | NZ_CP022686 | 494,360 | Δ1 bp | 5.1% | coding (282/351 nt) | flhD ← | flagellar transcriptional regulator FlhD |
| RA | NZ_CP022686 | 556,930 | C→G | 27.9% | intergenic (+114/‑734) | zinT → / → CIW80_RS03080 | metal‑binding protein ZinT/site‑specific integrase |
| RA | NZ_CP022686 | 556,942 | G→T | 18.0% | intergenic (+126/‑722) | zinT → / → CIW80_RS03080 | metal‑binding protein ZinT/site‑specific integrase |
| RA | NZ_CP022686 | 560,880 | C→T | 100% | intergenic (+62/+53) | CIW80_RS03085 → / ← pilV | hypothetical protein/shufflon system plasmid conjugative transfer pilus tip adhesin PilV |
| RA | NZ_CP022686 | 597,830 | A→C | 12.2% | D452A (GAC→GCC) | irp1 → | yersiniabactin polyketide synthase HMWP1 |
| RA | NZ_CP022686 | 601,295 | T→G | 18.3% | V1607G (GTC→GGC) | irp1 → | yersiniabactin polyketide synthase HMWP1 |
| RA | NZ_CP022686 | 601,302 | T→G | 17.4% | R1609R (CGT→CGG) | irp1 → | yersiniabactin polyketide synthase HMWP1 |
| MC JC | NZ_CP022686 | 628,478 | Δ1,286 bp | 100% | [clbP] | [clbP] | |
| RA | NZ_CP022686 | 651,848 | A→C | 9.4% | R238R (CGT→CGG) | clbJ ← | colibactin non‑ribosomal peptide synthetase ClbJ |
| RA | NZ_CP022686 | 756,115 | A→G | 100% | G181G (GGT→GGC) | galE ← | UDP‑glucose 4‑epimerase GalE |
| RA | NZ_CP022686 | 764,997 | T→G | 15.5% | N41T (AAC→ACC) | wcaM ← | colanic acid biosynthesis protein WcaM |
| RA | NZ_CP022686 | 766,757 | T→G | 18.1% | K290N (AAA→AAC) | wcaK ← | colanic acid biosynthesis pyruvyl transferase WcaK |
| RA | NZ_CP022686 | 794,460 | C→T | 100% | A568V (GCG→GTG) | dgcE → | diguanylate cyclase |
| RA | NZ_CP022686 | 829,441 | C→A | 24.6% | intergenic (‑30/+197) | gatY ← / ← fbaB | tagatose‑bisphosphate aldolase subunit GatY/class I fructose‑bisphosphate aldolase |
| RA | NZ_CP022686 | 829,452 | G→T | 14.0% | intergenic (‑41/+186) | gatY ← / ← fbaB | tagatose‑bisphosphate aldolase subunit GatY/class I fructose‑bisphosphate aldolase |
| RA | NZ_CP022686 | 829,467 | C→A | 27.7% | intergenic (‑56/+171) | gatY ← / ← fbaB | tagatose‑bisphosphate aldolase subunit GatY/class I fructose‑bisphosphate aldolase |
| RA | NZ_CP022686 | 829,472 | G→T | 13.3% | intergenic (‑61/+166) | gatY ← / ← fbaB | tagatose‑bisphosphate aldolase subunit GatY/class I fructose‑bisphosphate aldolase |
| RA | NZ_CP022686 | 881,760 | T→G | 19.0% | intergenic (+275/+112) | yohP → / ← dusC | protein YohP/tRNA dihydrouridine(16) synthase DusC |
| RA | NZ_CP022686 | 917,427:1 | +TT | 100% | intergenic (+130/‑91) | yeiP → / → yeiQ | elongation factor P‑like protein YeiP/mannitol dehydrogenase family protein |
| RA | NZ_CP022686 | 948,080 | G→T | 16.8% | intergenic (+149/‑108) | CIW80_RS04855 → / → CIW80_RS04860 | terminase small subunit/hypothetical protein |
| RA | NZ_CP022686 | 948,090 | C→A | 16.4% | intergenic (+159/‑98) | CIW80_RS04855 → / → CIW80_RS04860 | terminase small subunit/hypothetical protein |
| RA | NZ_CP022686 | 957,112 | T→G | 10.6% | T89P (ACC→CCC) | ccmA ← | cytochrome c biogenesis heme‑transporting ATPase CcmA |
| RA | NZ_CP022686 | 1,005,073 | A→C | 9.1% | E376D (GAA→GAC) | nrdA → | ribonucleoside‑diphosphate reductase subunit alpha |
| JC | NZ_CP022686 | 1,061,329 | Δ6 bp | 11.6% | coding (42‑47/945 nt) | lrhA ← | transcriptional regulator LrhA |
| RA | NZ_CP022686 | 1,065,997 | A→C | 10.9% | A30A (GCT→GCG) | yfbS ← | SLC13 family permease |
| RA | NZ_CP022686 | 1,100,944 | T→G | 12.4% | D187A (GAC→GCC) | aroC ← | chorismate synthase |
| RA | NZ_CP022686 | 1,145,575 | C→A | 11.8% | E332* (GAA→TAA) | oxc ← | oxalyl‑CoA decarboxylase |
| RA | NZ_CP022686 | 1,197,204 | T→G | 5.0% | V95G (GTA→GGA) | murQ → | N‑acetylmuramic acid 6‑phosphate etherase |
| RA | NZ_CP022686 | 1,209,935 | A→C | 16.5% | V387G (GTG→GGG) | eutH ← | ethanolamine utilization protein EutH |
| RA | NZ_CP022686 | 1,360,709 | T→G | 9.9% | intergenic (‑44/+280) | kgtP ← / ← rrf | alpha‑ketoglutarate permease/5S ribosomal RNA |
| RA | NZ_CP022686 | 1,360,724 | G→T | 10.1% | intergenic (‑59/+265) | kgtP ← / ← rrf | alpha‑ketoglutarate permease/5S ribosomal RNA |
| RA | NZ_CP022686 | 1,360,762 | G→T | 8.7% | intergenic (‑97/+227) | kgtP ← / ← rrf | alpha‑ketoglutarate permease/5S ribosomal RNA |
| RA | NZ_CP022686 | 1,366,277 | T→G | 8.3% | intergenic (‑278/+164) | CIW80_RS06740 ← / ← clpB | 16S ribosomal RNA/ATP‑dependent chaperone ClpB |
| RA | NZ_CP022686 | 1,370,559 | T→G | 15.9% | K98N (AAA→AAC) | rluD ← | 23S rRNA pseudouridine(1911/1915/1917) synthase RluD |
| RA | NZ_CP022686 | 1,392,487 | A→C | 9.5% | T43P (ACG→CCG) | lhgO → | L‑2‑hydroxyglutarate oxidase |
| RA | NZ_CP022686 | 1,443,501 | A→C | 12.8% | V20G (GTC→GGC) | hypF ← | carbamoyltransferase HypF |
| RA | NZ_CP022686 | 1,460,615 | A→C | 15.7% | K673N (AAA→AAC) | flhA → | formate hydrogenlyase transcriptional activator FlhA |
| RA | NZ_CP022686 | 1,479,607 | A→C | 12.3% | intergenic (‑16/+177) | ftsB ← / ← ygbE | cell division protein FtsB/DUF3561 family protein |
| RA | NZ_CP022686 | 1,479,619 | T→A | 11.7% | intergenic (‑28/+165) | ftsB ← / ← ygbE | cell division protein FtsB/DUF3561 family protein |
| RA | NZ_CP022686 | 1,504,355 | T→A | 12.8% | A264A (GCT→GCA) | CIW80_RS07520 → | YgcG family protein |
| RA | NZ_CP022686 | 1,504,361 | G→T | 17.5% | V266V (GTG→GTT) | CIW80_RS07520 → | YgcG family protein |
| RA | NZ_CP022686 | 1,558,395 | A→C | 13.6% | K464N (AAA→AAC) | vgrG → | type VI secretion system Vgr family protein |
| RA | NZ_CP022686 | 1,564,569 | A→C | 11.9% | K190N (AAA→AAC) | CIW80_RS07780 → | ImcF‑related family protein |
| RA | NZ_CP022686 | 1,597,246 | C→G | 7.8% | G15A (GGC→GCC) | thyA ← | thymidylate synthase |
| RA | NZ_CP022686 | 1,632,501 | T→G | 9.3% | V166G (GTT→GGT) | arcC → | carbamate kinase |
| RA | NZ_CP022686 | 1,633,846 | T→G | 34.2% | N253T (AAC→ACC) | yqeB ← | selenium‑dependent molybdenum cofactor biosynthesis protein YqeB |
| RA | NZ_CP022686 | 1,640,925 | A→C | 14.0% | R7S (AGA→AGC) | ygfM → | molybdopterin‑dependent oxidoreductase FAD‑binding subunit |
| RA | NZ_CP022686 | 1,674,224 | T→G | 16.5% | K188N (AAA→AAC) | ygfB ← | UPF0149 family protein YgfB |
| RA | NZ_CP022686 | 1,674,248 | T→G | 12.1% | Q180H (CAA→CAC) | ygfB ← | UPF0149 family protein YgfB |
| RA | NZ_CP022686 | 1,705,755 | T→G | 9.3% | intergenic (‑365/‑290) | yqgB ← / → metK | acid stress response protein YqgB/methionine adenosyltransferase |
| RA | NZ_CP022686 | 1,705,974 | T→G | 14.5% | intergenic (‑584/‑71) | yqgB ← / → metK | acid stress response protein YqgB/methionine adenosyltransferase |
| RA | NZ_CP022686 | 1,860,070 | C→A | 14.8% | E119* (GAA→TAA) | CIW80_RS09255 ← | YtfJ family protein |
| RA | NZ_CP022686 | 1,925,332 | A→C | 9.6% | N151T (AAC→ACC) | ygiB → | DUF1190 family protein |
| RA | NZ_CP022686 | 1,954,923 | T→G | 15.9% | T92P (ACG→CCG) | ttdR ← | DNA‑binding transcriptional activator TtdR |
| RA | NZ_CP022686 | 1,964,332 | A→C | 7.4% | G27G (GGT→GGG) | mug ← | G/U mismatch‑specific DNA glycosylase |
| RA | NZ_CP022686 | 1,965,173 | A→C | 8.7% | R86R (CGT→CGG) | nfeF ← | NADPH‑dependent ferric chelate reductase |
| RA | NZ_CP022686 | 2,016,175 | T→G | 8.2% | noncoding (99/377 nt) | rnpB ← | RNase P RNA component class A |
| RA | NZ_CP022686 | 2,037,521 | A→C | 8.6% | T508P (ACC→CCC) | lpoA → | penicillin‑binding protein activator LpoA |
| RA | NZ_CP022686 | 2,044,069 | T→G | 5.8% | R197R (CGT→CGG) | ubiU → | peptidase U32 family protein |
| RA | NZ_CP022686 | 2,049,089 | T→G | 19.1% | N256T (AAC→ACC) | deaD ← | ATP‑dependent RNA helicase DeaD |
| RA | NZ_CP022686 | 2,049,094 | G→T | 13.4% | T254T (ACC→ACA) | deaD ← | ATP‑dependent RNA helicase DeaD |
| RA | NZ_CP022686 | 2,056,168 | A→C | 9.8% | G614G (GGT→GGG) | infB ← | translation initiation factor IF‑2 |
| RA | NZ_CP022686 | 2,061,785 | A→C | 11.1% | E385A (GAG→GCG) | argG → | argininosuccinate synthase |
| RA | NZ_CP022686 | 2,076,554 | T→G | 10.3% | intergenic (+24/‑209) | ispB → / → sfsB | octaprenyl diphosphate synthase/DNA‑binding transcriptional regulator SfsB |
| RA | NZ_CP022686 | 2,076,556 | C→G | 7.2% | intergenic (+26/‑207) | ispB → / → sfsB | octaprenyl diphosphate synthase/DNA‑binding transcriptional regulator SfsB |
| RA | NZ_CP022686 | 2,110,457 | T→G | 8.6% | K12N (AAA→AAC) | rplM ← | 50S ribosomal protein L13 |
| RA | NZ_CP022686 | 2,110,461 | A→T | 8.1% | V11E (GTA→GAA) | rplM ← | 50S ribosomal protein L13 |
| RA | NZ_CP022686 | 2,110,465 | T→G | 9.2% | T10P (ACC→CCC) | rplM ← | 50S ribosomal protein L13 |
| RA | NZ_CP022686 | 2,123,236 | A→C | 8.2% | G209G (GGT→GGG) | tldD ← | metalloprotease TldD |
| RA | NZ_CP022686 | 2,130,829 | A→C | 8.3% | V237G (GTT→GGT) | mreC ← | rod shape‑determining protein MreC |
| RA | NZ_CP022686 | 2,148,109 | T→G | 17.5% | V124G (GTG→GGG) | panF → | sodium/pantothenate symporter |
| RA | NZ_CP022686 | 2,148,115 | T→G | 12.2% | L126R (CTG→CGG) | panF → | sodium/pantothenate symporter |
| RA | NZ_CP022686 | 2,148,136 | T→G | 12.4% | V133G (GTT→GGT) | panF → | sodium/pantothenate symporter |
| RA | NZ_CP022686 | 2,172,177 | A→C | 5.1% | G87G (GGT→GGG) | smg ← | DUF494 family protein Smg |
| RA | NZ_CP022686 | 2,179,878 | T→G | 8.8% | K35T (AAG→ACG) | rplQ ← | 50S ribosomal protein L17 |
| RA | NZ_CP022686 | 2,185,075 | A→C | 10.6% | V46G (GTT→GGT) | rpsE ← | 30S ribosomal protein S5 |
| RA | NZ_CP022686 | 2,188,239 | G→T | 7.5% | intergenic (‑108/+57) | rplN ← / ← rpsQ | 50S ribosomal protein L14/30S ribosomal protein S17 |
| RA | NZ_CP022686 | 2,214,419 | T→C | 100% | K43R (AAA→AGA) | rpsL ← | 30S ribosomal protein S12 |
| RA | NZ_CP022686 | 2,320,775 | C→T | 100% | G274S (GGC→AGC) | CIW80_RS11675 ← | DNA‑processing protein DprA |
| RA | NZ_CP022686 | 2,353,098 | T→G | 7.2% | F83V (TTT→GTT) | yhhN → | lysoplasmalogenase |
| RA | NZ_CP022686 | 2,357,291 | A→C | 11.1% | N26T (AAC→ACC) | dcrB → | phage sensitivity protein DcrB |
| RA | NZ_CP022686 | 2,357,324 | A→C | 19.8% | N37T (AAC→ACC) | dcrB → | phage sensitivity protein DcrB |
| RA | NZ_CP022686 | 2,361,493 | A→T | 7.7% | L189F (TTA→TTT) | nikA → | nickel ABC transporter substrate‑binding protein |
| RA | NZ_CP022686 | 2,393,013 | T→G | 6.1% | intergenic (+151/‑2) | slp → / → dctR | outer membrane lipoprotein Slp/LuxR C‑terminal‑related transcriptional regulator |
| RA | NZ_CP022686 | 2,394,287 | T→G | 13.5% | N115T (AAC→ACC) | chuS ← | hematinate‑forming heme oxygenase ChuS |
| RA | NZ_CP022686 | 2,408,861 | Δ1 bp | 100% | pseudogene (1097/3115 nt) | mdtF → | multidrug efflux pump RND permease MdtF |
| RA | NZ_CP022686 | 2,410,581 | A→C | 6.5% | pseudogene (2817/3115 nt) | mdtF → | multidrug efflux pump RND permease MdtF |
| RA | NZ_CP022686 | 2,460,579 | T→A | 21.9% | intergenic (‑1/‑157) | yhjY ← / → tag | autotransporter outer membrane beta‑barrel domain‑containing protein/DNA‑3‑methyladenine glycosylase I |
| RA | NZ_CP022686 | 2,546,408 | C→A | 10.5% | M90I (ATG→ATT) | waaG ← | glycosyltransferase family 4 protein |
| RA | NZ_CP022686 | 2,574,429 | T→G | 13.2% | N230T (AAC→ACC) | CIW80_RS12895 ← | class II fructose‑bisphosphate aldolase family protein |
| RA | NZ_CP022686 | 2,574,451 | T→G | 10.7% | T223P (ACT→CCT) | CIW80_RS12895 ← | class II fructose‑bisphosphate aldolase family protein |
| JC | NZ_CP022686 | 2,590,563 | +TTGG | 100% | coding (109/153 nt) | CIW80_RS26455 → | hypothetical protein |
| RA | NZ_CP022686 | 2,733,571 | T→G | 8.1% | F53V (TTT→GTT) | rffG → | dTDP‑glucose 4,6‑dehydratase |
| RA | NZ_CP022686 | 2,733,577 | T→G | 10.8% | F55V (TTT→GTT) | rffG → | dTDP‑glucose 4,6‑dehydratase |
| RA | NZ_CP022686 | 2,743,563 | T→G | 9.4% | noncoding (65/87 nt) | CIW80_RS13750 → | tRNA‑Leu |
| RA | NZ_CP022686 | 2,758,128 | A→C | 11.6% | K40N (AAA→AAC) | yifL → | lipoprotein |
| RA | NZ_CP022686 | 2,758,138 | A→C | 11.0% | T44P (ACG→CCG) | yifL → | lipoprotein |
| RA | NZ_CP022686 | 2,758,153 | A→C | 13.4% | T49P (ACG→CCG) | yifL → | lipoprotein |
| RA | NZ_CP022686 | 2,758,168 | A→C | 7.3% | N54H (AAC→CAC) | yifL → | lipoprotein |
| RA | NZ_CP022686 | 2,799,502 | C→A | 7.9% | L82F (TTG→TTT) | CIW80_RS14015 ← | tripartite tricarboxylate transporter permease |
| RA | NZ_CP022686 | 2,801,864 | T→G | 6.9% | L16F (TTA→TTC) | CIW80_RS14030 ← | 2‑dehydro‑3‑deoxy‑6‑phosphogalactonate aldolase |
| RA | NZ_CP022686 | 2,868,753 | T→G | 12.3% | T18P (ACC→CCC) | fdoH ← | formate dehydrogenase O subunit beta |
| RA | NZ_CP022686 | 2,871,422 | T→G | 9.1% | N149T (AAC→ACC) | fdnG ← | formate dehydrogenase‑N subunit alpha |
| RA | NZ_CP022686 | 2,920,428 | A→C | 9.3% | K68N (AAA→AAC) | CIW80_RS14610 → | bifunctional UDP‑sugar hydrolase/5'‑nucleotidase |
| RA | NZ_CP022686 | 2,937,218 | C→A | 10.2% | E216* (GAA→TAA) | yijO ← | AraC family transcriptional regulator |
| RA | NZ_CP022686 | 2,981,597 | G→T | 14.3% | E562* (GAA→TAA) | rpoC → | DNA‑directed RNA polymerase subunit beta' |
| RA | NZ_CP022686 | 2,981,612 | A→C | 7.4% | T567P (ACC→CCC) | rpoC → | DNA‑directed RNA polymerase subunit beta' |
| RA | NZ_CP022686 | 2,981,625 | A→C | 8.6% | D571A (GAC→GCC) | rpoC → | DNA‑directed RNA polymerase subunit beta' |
| RA | NZ_CP022686 | 2,989,627 | T→G | 10.3% | Q39H (CAA→CAC) | thiC ← | phosphomethylpyrimidine synthase ThiC |
| RA | NZ_CP022686 | 3,013,752 | T→G | 10.7% | V471G (GTG→GGG) | aceK → | bifunctional isocitrate dehydrogenase kinase/phosphatase |
| RA | NZ_CP022686 | 3,020,229 | T→G | 16.5% | V133G (GTC→GGC) | yjbB → | Na/Pi cotransporter family protein |
| RA | NZ_CP022686 | 3,020,414 | A→C | 5.9% | T195P (ACC→CCC) | yjbB → | Na/Pi cotransporter family protein |
| RA | NZ_CP022686 | 3,136,940 | T→G | 7.6% | D161A (GAC→GCC) | phnN ← | ribose 1,5‑bisphosphokinase |
| JC | NZ_CP022686 | 3,196,873 | +GCGTAATCGGTT | 100% | coding (944/1122 nt) | ampC ← | BlaEC family class C beta‑lactamase |
| RA | NZ_CP022686 | 3,225,762 | A→C | 6.6% | L266F (TTA→TTC) | rnr → | ribonuclease R |
| RA | NZ_CP022686 | 3,252,190 | T→G | 13.5% | K221N (AAA→AAC) | CIW80_RS16225 ← | enoyl‑CoA hydratase/isomerase family protein |
| RA | NZ_CP022686 | 3,363,064 | C→A | 6.6% | intergenic (+763/‑28) | CIW80_RS16815 → / → CIW80_RS16820 | helix‑turn‑helix domain‑containing protein/Alw26I/Eco31I/Esp3I family type II restriction adenine‑specific DNA‑methyltransferase |
| RA | NZ_CP022686 | 3,424,795 | A→C | 100% | intergenic (‑41/+27) | yjiJ ← / ← yjiK | MFS transporter/YjiK family protein |
| RA | NZ_CP022686 | 3,461,199 | T→A | 9.9% | intergenic (‑8/+27) | CIW80_RS17335 ← / ← CIW80_RS17340 | tRNA‑Leu/tRNA‑Leu |
| RA | NZ_CP022686 | 3,461,215 | A→T | 13.4% | intergenic (‑24/+11) | CIW80_RS17335 ← / ← CIW80_RS17340 | tRNA‑Leu/tRNA‑Leu |
| RA | NZ_CP022686 | 3,461,218 | G→C | 10.1% | intergenic (‑27/+8) | CIW80_RS17335 ← / ← CIW80_RS17340 | tRNA‑Leu/tRNA‑Leu |
| RA | NZ_CP022686 | 3,461,221 | T→G | 14.5% | intergenic (‑30/+5) | CIW80_RS17335 ← / ← CIW80_RS17340 | tRNA‑Leu/tRNA‑Leu |
| RA | NZ_CP022686 | 3,461,223 | G→T | 12.7% | intergenic (‑32/+3) | CIW80_RS17335 ← / ← CIW80_RS17340 | tRNA‑Leu/tRNA‑Leu |
| RA | NZ_CP022686 | 3,461,224 | T→G | 15.8% | intergenic (‑33/+2) | CIW80_RS17335 ← / ← CIW80_RS17340 | tRNA‑Leu/tRNA‑Leu |
| RA | NZ_CP022686 | 3,461,229 | T→G | 17.7% | noncoding (84/87 nt) | CIW80_RS17340 ← | tRNA‑Leu |
| RA | NZ_CP022686 | 3,493,370 | T→G | 5.9% | K195N (AAA→AAC) | arcA ← | two‑component system response regulator ArcA |
| RA | NZ_CP022686 | 3,504,054 | T→G | 5.9% | V204G (GTT→GGT) | tal → | transaldolase |
| RA | NZ_CP022686 | 3,528,218 | A→C | 8.6% | D57A (GAC→GCC) | carB → | carbamoyl‑phosphate synthase large subunit |
| RA | NZ_CP022686 | 3,547,903 | T→G | 7.0% | F15V (TTT→GTT) | CIW80_RS17770 → | CcdB family protein |
| RA | NZ_CP022686 | 3,625,704 | T→G | 8.8% | R157R (CGT→CGG) | aceE → | pyruvate dehydrogenase (acetyl‑transferring), homodimeric type |
| RA | NZ_CP022686 | 3,655,528 | C→A | 7.0% | E769* (GAA→TAA) | htrE ← | outer membrane usher protein |
| RA | NZ_CP022686 | 3,656,188 | A→G | 100% | S549P (TCC→CCC) | htrE ← | outer membrane usher protein |
| RA | NZ_CP022686 | 3,734,367 | T→G | 16.1% | F225V (TTT→GTT) | yafD → | endonuclease/exonuclease/phosphatase family protein |
| RA | NZ_CP022686 | 3,770,508 | T→G | 9.1% | intergenic (‑244/+219) | CIW80_RS26265 ← / ← CIW80_RS18890 | ATP‑binding protein/hypothetical protein |
| RA | NZ_CP022686 | 3,770,520 | G→T | 9.0% | intergenic (‑256/+207) | CIW80_RS26265 ← / ← CIW80_RS18890 | ATP‑binding protein/hypothetical protein |
| RA | NZ_CP022686 | 3,776,865 | C→A | 8.1% | L123M (CTG→ATG) | CIW80_RS18945 → | inovirus‑type Gp2 protein |
| RA | NZ_CP022686 | 3,792,805 | A→G | 100% | Y421C (TAC→TGC) | fucP → | L‑fucose:H+ symporter permease |
| RA | NZ_CP022686 | 3,797,481 | T→G | 19.2% | L130V (TTA→GTA) | CIW80_RS19065 → | LacI family DNA‑binding transcriptional regulator |
| RA | NZ_CP022686 | 3,800,981 | A→C | 12.6% | pseudogene (1257/1773 nt) | CIW80_RS19080 → | ShlB/FhaC/HecB family hemolysin secretion/activation protein |
| RA | NZ_CP022686 | 3,897,759 | A→T | 12.1% | pseudogene (117/1083 nt) | hyxB ← | outer membrane autotransporter HyxB |
| RA | NZ_CP022686 | 3,925,289 | A→C | 17.5% | N156T (AAC→ACC) | prpC → | 2‑methylcitrate synthase |
| RA | NZ_CP022686 | 3,925,304 | A→C | 12.4% | Q161P (CAG→CCG) | prpC → | 2‑methylcitrate synthase |
| RA | NZ_CP022686 | 3,925,309 | G→T | 12.4% | E163* (GAA→TAA) | prpC → | 2‑methylcitrate synthase |
| RA | NZ_CP022686 | 4,014,242 | A→T | 10.2% | intergenic (+88/‑256) | bolA → / → tig | transcriptional regulator BolA/trigger factor |
| RA | NZ_CP022686 | 4,014,247 | G→T | 10.4% | intergenic (+93/‑251) | bolA → / → tig | transcriptional regulator BolA/trigger factor |
| RA | NZ_CP022686 | 4,056,962 | C→A | 17.1% | F137L (TTC→TTA) | adk → | adenylate kinase |
| RA | NZ_CP022686 | 4,196,276 | T→G | 16.4% | E15D (GAA→GAC) | holA ← | DNA polymerase III subunit delta |
| RA | NZ_CP022686 | 4,290,599 | T→G | 6.2% | T121P (ACC→CCC) | ybgS ← | YbgS‑like family protein |
| RA | NZ_CP022686 | 4,368,341 | T→G | 12.0% | D47A (GAC→GCC) | ybiY ← | glycyl‑radical enzyme activating protein |
| RA | NZ_CP022686 | 4,368,372 | T→G | 12.9% | S37R (AGC→CGC) | ybiY ← | glycyl‑radical enzyme activating protein |
| RA | NZ_CP022686 | 4,368,380 | T→G | 11.0% | N34T (AAC→ACC) | ybiY ← | glycyl‑radical enzyme activating protein |
| RA | NZ_CP022686 | 4,440,297 | T→A | 12.4% | V785D (GTT→GAT) | ftsK → | DNA translocase FtsK |
| RA | NZ_CP022686 | 4,440,334 | A→C | 22.8% | Q797H (CAA→CAC) | ftsK → | DNA translocase FtsK |
| RA | NZ_CP022686 | 4,531,313 | A→C | 7.4% | E62D (GAA→GAC) | hyaF → | hydrogenase expression/formation protein |
| RA | NZ_CP022686 | 4,571,459 | G→T | 12.7% | F52L (TTC→TTA) | pgaC ← | poly‑beta‑1,6‑N‑acetyl‑D‑glucosamine synthase |
| RA | NZ_CP022686 | 4,632,182 | T→G | 8.9% | R276R (CGT→CGG) | mchF → | microcin export transporter peptidase/ATP‑binding subunit MchF |
| RA | NZ_CP022686 | 4,712,763 | A→C | 16.3% | A52A (GCT→GCG) | yceB ← | lipoprotein |
| RA | NZ_CP022686 | 4,764,877 | T→G | 13.8% | intergenic (‑57/‑204) | ycfT ← / → lolC | acyltransferase family protein/lipoprotein‑releasing ABC transporter permease subunit LolC |
| RA | NZ_CP022686 | 4,780,061 | T→C | 16.0% | H14R (CAC→CGC) | phoP ← | two‑component system response regulator PhoP |
| RA | NZ_CP022686 | 4,809,441 | T→G | 10.9% | G50G (GGT→GGG) | CIW80_RS24260 → | head‑tail joining protein |
| RA | NZ_CP022686 | 4,870,912 | Δ1 bp | 100% | intergenic (‑108/‑120) | dhaK ← / → dhaR | dihydroxyacetone kinase subunit DhaK/dihydroxyacetone kinase operon transcriptional regulator DhaR |
| RA | NZ_CP022686 | 4,905,170 | T→G | 16.9% | V99G (GTT→GGT) | CIW80_RS24815 → | coenzyme F390 synthetase |
| RA | NZ_CP022686 | 4,918,846 | C→A | 9.1% | Q387H (CAG→CAT) | adhE ← | bifunctional acetaldehyde‑CoA/alcohol dehydrogenase |
| RA | NZ_CP022686 | 4,951,545 | A→C | 14.0% | S47R (AGT→CGT) | topA → | type I DNA topoisomerase |
| RA | NZ_CP022686 | 5,001,157 | G→T | 17.7% | D161Y (GAT→TAT) | ompG → | monomeric porin OmpG |
| RA | NZ_CP022686 | 5,042,304 | T→C | 11.1% | N645N (AAT→AAC) | CIW80_RS25525 → | EntS/YbdA MFS transporter |
| RA | NZ_CP022686 | 5,043,855 | T→C | 9.8% | G1162G (GGT→GGC) | CIW80_RS25525 → | EntS/YbdA MFS transporter |
| RA | NZ_CP022686 | 5,044,641 | C→T | 5.2% | N1424N (AAC→AAT) | CIW80_RS25525 → | EntS/YbdA MFS transporter |
| RA | pMUT1‑hok‑empty | 4,123:1 | +T | 92.9% | intergenic (‑341/–) | putative rom (RNA I inhibition modulator protein) ← / – | –/– |
| RA | pMUT1‑hok‑empty | 4,127 | C→A | 100% | intergenic (‑345/–) | putative rom (RNA I inhibition modulator protein) ← / – | –/– |
| RA | pMUT1‑hok‑empty | 4,132 | 4 bp→TA | 100% | intergenic (‑350/–) | putative rom (RNA I inhibition modulator protein) ← / – | –/– |
| Unassigned missing coverage evidence | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| seq id | start | end | size | ←reads | reads→ | gene | description | |||
| * | * | ÷ | NZ_MW240712 | 189–287 | 3085–2956 | 2670–2897 | 7916 [7335] | [7670] 7795 | JNG15_RS00005–mobA | JNG15_RS00005,JNG15_RS00010,JNG15_RS00015,mobA |
| * | * | ÷ | pMUT1‑hok‑empty | 1263–1317 | 3987–1722 | 406–2725 | 3312 [3134] | [3242] 3646 | putative HTH domain protein–putative rom (RNA I inhibition modulator protein) | putative HTH domain protein,uncharacterized protein,hypothetical protein,putative rom (RNA I inhibition modulator protein) |
| Unassigned new junction evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NZ_CP022686 | 3899666 = | 121 (0.660) | 87 (0.550) | 47/216 | NT | 46.0% | intergenic (‑40/+290) | hyxR/ipbA | LuxR family transcriptional regulator HyxR/tyrosine‑type DNA invertase IpbA |
| ? | NZ_CP022686 | 3899944 = | 99 (0.620) | intergenic (‑318/+12) | hyxR/ipbA | LuxR family transcriptional regulator HyxR/tyrosine‑type DNA invertase IpbA | |||||
| * | ? | NZ_CP022686 | = 3899681 | 118 (0.650) | 83 (0.520) | 49/216 | NT | 45.1% | intergenic (‑55/+275) | hyxR/ipbA | LuxR family transcriptional regulator HyxR/tyrosine‑type DNA invertase IpbA |
| ? | NZ_CP022686 | = 3899927 | 99 (0.620) | intergenic (‑301/+29) | hyxR/ipbA | LuxR family transcriptional regulator HyxR/tyrosine‑type DNA invertase IpbA | |||||
| * | ? | pMUT1‑hok‑empty | 456 = | 2567 (0.480) | 3603 (0.670) | 213/248 | NT | 66.7% | intergenic (–/+1261) | –/putative HTH domain protein | –/– |
| ? | pMUT1‑hok‑empty | 4136 = | 1033 (0.190) | intergenic (‑354/–) | putative rom (RNA I inhibition modulator protein)/– | –/– | |||||
| * | ? | pMUT1‑hok‑empty | = 491 | 3638 (0.680) | 2959 (0.690) | 169/198 | NT | 60.1% | intergenic (–/+1226) | –/putative HTH domain protein | –/– |
| ? | pMUT1‑hok‑empty | = 4098 | 1028 (0.240) | intergenic (‑316/–) | putative rom (RNA I inhibition modulator protein)/– | –/– | |||||